Canavan disease
Definition
The ASPA gene encodes aspartoacylase, the enzyme that breaks down N-acetyl-L-aspartic acid (NAA) in neurons; deficiency leads to accumulation of NAA and disrupts myelin formation. In the severe infantile form, developmental delay, hypotonia, macrocephaly and seizures appear at 3 to 5 months of age; the juvenile form presents with delayed speech/motor development.
Gene/region examined
ASPA - Exon 1, ASPA - Exon 2, ASPA - Exon 3, ASPA - Exon 4, ASPA - Exon 5, ASPA - Exon 6
Method
Sequence analysis
Accepted sample types
EDTA blood, AF, CVS
Inheritance
Hereditary, autosomal recessive; particularly common in the Ashkenazi Jewish population.